Swedish biotech company Gesynta Pharma AB has secured $27 million in a Series B financing round led by Innovestor Life Science in Finland.
Gov. Ned Lamont’s two-year budget proposal maintains funding for a new state partnership to continue research and education ...
How closely have you kept up with Canadian tech and innovation news this month? Test your knowledge and see how you compare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback